ARTICLES BY ERIN HARRIS
-
![DNA Strand]( "What The Gene Therapy Sector Doesn’t Understand About CRISPR")
What The Gene Therapy Sector Doesn’t Understand About CRISPR11/25/2020I sat down with Sadik Kassim, Chief Technical Officer at Vor Biopharma to discuss the benefits of CRISPR-engineered stem cell therapies, the challenges and feasible solutions, what’s next, and more.
-
![Cell Gene]( "Inside Sangamo’s Decision to Build an In-House AAV Manufacturing Facility")
Inside Sangamo’s Decision to Build an In-House AAV Manufacturing Facility9/11/2020Andy Ramelmeier, EVP Technical Operations at Sangamo Therapeutics and I sat down to discuss Sangamo’s plans for its in-house AAV manufacturing facility and the major benefits the facility will bring to genomic medicine and the sector at large.
-
![gene_therapy_dna_istock]( "The Unique Demands of Cell and Gene Therapy Supply Chains")
The Unique Demands of Cell and Gene Therapy Supply Chains4/10/2019Three cell and gene therapy sector SMEs representing industry and academia explain supply chain challenges and viable solutions.
Erin Harris
Click here to email Erin.
Erin Harris is chief editor of Cell & Gene and a contributing editor to Life Science Leader magazine. She studied English and psychology at Lafayette College and has 20+ years of experience in B2B publishing. Erin spent 10 years covering and reporting on the adoption of information technology from a B2B perspective. She’s written on technology topics ranging from Big Data and analytics to security and e-commerce. In each case, her reporting centered on innovations that improved operational efficiencies, fostered interdepartmental collaboration, or enhanced supply chains. Currently, she writes actionable information for professionals involved in the development and commercialization of cell and gene therapies. She covers the entire product lifecycle from basic research to commercialization. Erin has interviewed executives from Fortune 500 as well as startups. She has moderated panel discussions and has spoken at numerous industry events from large conferences to niche forums.